Notable Labs Files for Chapter 7 Bankruptcy

Dow Jones
15 Oct 2024
 

By Stephen Nakrosis

 

Biotechnology company Notable Labs said Tuesday it had voluntarily filed for chapter 7 bankruptcy and will liquidate.

The company said its decision comes after considering strategic alternatives.

Last month, the company said it would pause implementation of a planned Phase 2 study of cancer drug Volasertib in relapsed/refractory acute myeloid leukemia. The company also said it was reducing its workforce and outside consultants by approximately 65%.

Notable said the court would appoint a trustee to administer the bankruptcy estates, adding the company and its subsidiaries will be liquidated.

Also on Tuesday, Notable said all members of its board resigned. In addition, Chief Financial Officer Scott McPherson, and Joseph Wagner, the company's chief scientific officer, were terminated, effective Oct. 8. Interim Chief Executive Officer Kaile Zagger was also terminated and will serve as an advisor to the company effective as of that date.

 

Write to Stephen Nakrosis at stephen.nakrosis@wsj.com

 

(END) Dow Jones Newswires

October 15, 2024 06:50 ET (10:50 GMT)

Copyright (c) 2024 Dow Jones & Company, Inc.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10